NCT02464670: Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers |
|
|
| Completed | 1 | 240 | US | INO-4201, INO-4202, INO-4212, INO-4212 + INO-9012, INO-4201 + INO-9012 | Inovio Pharmaceuticals, GeneOne Life Science, Inc., Defense Advanced Research Projects Agency | Ebola Vaccine | 05/18 | 05/18 | | |
| Completed | 1 | 46 | Europe | INO-4201, Placebo | University of Geneva, Switzerland, Defense Advanced Research Projects Agency, Global Urgent and Advanced Research and Development (GuardRX), Inovio Pharmaceuticals | Ebola Virus Disease | 01/22 | 05/22 | | |